Michael J Pencina
Overview
Explore the profile of Michael J Pencina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
316
Citations
26835
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pencina M, Thompson B
NEJM Evid
. 2024 Feb;
1(6):EVIDctw2200060.
PMID: 38319278
Innovation in Clinical Trials in the 21st CenturyMedical evidence is rooted in randomized controlled trials but there is a pressing need for innovative designs. Pencina and Thompson introduce a new...
12.
Economou-Zavlanos N, Bessias S, Cary Jr M, Bedoya A, Goldstein B, Jelovsek J, et al.
J Am Med Inform Assoc
. 2023 Nov;
31(3):705-713.
PMID: 38031481
Objective: The complexity and rapid pace of development of algorithmic technologies pose challenges for their regulation and oversight in healthcare settings. We sought to improve our institution's approach to evaluation...
13.
Overgaard S, Graham M, Brereton T, Pencina M, Halamka J, Vidal D, et al.
NPJ Digit Med
. 2023 Nov;
6(1):218.
PMID: 38007604
No abstract available.
14.
Khan S, Coresh J, Pencina M, Ndumele C, Rangaswami J, Chow S, et al.
Circulation
. 2023 Nov;
148(24):1982-2004.
PMID: 37947094
Cardiovascular-kidney-metabolic (CKM) syndrome is a novel construct recently defined by the American Heart Association in response to the high prevalence of metabolic and kidney disease. Epidemiological data demonstrate higher absolute...
15.
Khan S, Matsushita K, Sang Y, Ballew S, Grams M, Surapaneni A, et al.
Circulation
. 2023 Nov;
149(6):430-449.
PMID: 37947085
Background: Multivariable equations are recommended by primary prevention guidelines to assess absolute risk of cardiovascular disease (CVD). However, current equations have several limitations. Therefore, we developed and validated the American...
16.
Mallya P, Stevens L, Zhao J, Hong C, Henao R, Economou-Zavlanos N, et al.
Circ Cardiovasc Qual Outcomes
. 2023 Oct;
16(11):e009938.
PMID: 37850400
Background: High-quality research in cardiovascular prevention, as in other fields, requires inclusion of a broad range of data sets from different sources. Integrating and harmonizing different data sources are essential...
17.
Ndumele C, Rangaswami J, Chow S, Neeland I, Tuttle K, Khan S, et al.
Circulation
. 2023 Oct;
148(20):1606-1635.
PMID: 37807924
Cardiovascular-kidney-metabolic health reflects the interplay among metabolic risk factors, chronic kidney disease, and the cardiovascular system and has profound impacts on morbidity and mortality. There are multisystem consequences of poor...
18.
Ndumele C, Neeland I, Tuttle K, Chow S, Mathew R, Khan S, et al.
Circulation
. 2023 Oct;
148(20):1636-1664.
PMID: 37807920
A growing appreciation of the pathophysiological interrelatedness of metabolic risk factors such as obesity and diabetes, chronic kidney disease, and cardiovascular disease has led to the conceptualization of cardiovascular-kidney-metabolic syndrome....
19.
Cary Jr M, Zink A, Wei S, Olson A, Yan M, Senior R, et al.
Health Aff (Millwood)
. 2023 Oct;
42(10):1359-1368.
PMID: 37782868
In August 2022 the Department of Health and Human Services (HHS) issued a notice of proposed rulemaking prohibiting covered entities, which include health care providers and health plans, from discriminating...
20.
Solnica B, Sniderman A, Wyszomirski A, Rutkowski M, Chlebus K, Bandosz P, et al.
Int J Cardiol
. 2023 Jul;
390:131150.
PMID: 37429441
Background: The study compared the distribution of serum LDL-C, non-HDL-C, and apolipoprotein B (apoB) among participants of the NATPOL 2011 survey and analysed concordance/discordance of results in the context of...